Also, avoid low-sodium salt substitutes, as these are often made of potassium chloride
Certain medications may also interact with Semaglutide treatment, necessitating a dose adjustment in either the other medication or in the amount of Semaglutide or Compounded Semaglutide. For example, administering injectable Semaglutide with insulin or an insulin secretagogue can cause hypoglycemia (low blood sugar)
More concerning, though rare, is the risk of acute pancreatitis, which has been reported with GLP-1 receptor agonists and is noted in the Warnings and Precautions sections of the prescribing information
In addition to its effects on appetite and weight loss, Semaglutide GLP-1 also stimulates the production of insulin in response to food intake, which helps to lower blood sugar levels
effectiveness of the intervention